Association between longer therapy with thiazolidinediones and risk of bladder cancer: a cohort study.
about
Real world evidence: An Indian perspectiveImpact of glucose-lowering agents on the risk of cancer in type 2 diabetic patients. The Barcelona case-control studyEfficacy and safety of tangshen formula on patients with type 2 diabetic kidney disease: a multicenter double-blinded randomized placebo-controlled trialIncidence and Mortality Risks of Cancer in Patients with Type 2 Diabetes: A Retrospective Study in Shanghai, ChinaGeneralized enrichment analysis improves the detection of adverse drug events from the biomedical literatureThe current role of thiazolidinediones in diabetes management.Cost-utility analysis of nonalcoholic steatohepatitis screening.Evaluation of methods to estimate missing days' supply within pharmacy data of the Clinical Practice Research Datalink (CPRD) and The Health Improvement Network (THIN).Optimal therapy of type 2 diabetes: a controversial challengeLatest insights into the risk of cancer in diabetesIncidence of bladder cancer in patients with type 2 diabetes treated with metformin or sulfonylureas.Thiazolidinediones and associated risk of bladder cancer: a systematic review and meta-analysisA Review on the Relationship between SGLT2 Inhibitors and Cancer.Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention.Diabetic oncopathy--one more yet another deadly diabetic complication!The peroxisome-proliferator activated receptor-γ agonist pioglitazone modulates aberrant T cell responses in systemic lupus erythematosus.Cardiovascular impact of drugs used in the treatment of diabetesPioglitazone use and risk of bladder cancer: population based cohort study.Utilisation trends of rosiglitazone and pioglitazone in Australia before and after safety warnings.Incidence and Survival of urothelial carcinoma of the urinary bladder in Norway 1981-2014.Management of type 2 diabetes mellitus in older adults.Survival analysis using primary care electronic health record data: A systematic review of the literature.Obesity-driven inflammation and cancer risk: role of myeloid derived suppressor cells and alternately activated macrophages.Rosiglitazone Use and the Risk of Bladder Cancer in Patients With Type 2 Diabetes.Diabetes and risk of bladder cancer among postmenopausal women in the Iowa Women's Health Study.Pioglitazone: A prudent prescription.Mechanisms of current therapies for diabetes mellitus type 2Urinary tuberculosis is associated with the development of urothelial carcinoma but not renal cell carcinoma: a nationwide cohort study in Taiwan.Pseudoginsenoside F11, a Novel Partial PPAR γ Agonist, Promotes Adiponectin Oligomerization and Secretion in 3T3-L1 AdipocytesTargets for body fat, blood pressure, lipids, and glucose-lowering interventions in healthy older people.Risk of bladder cancer among patients with diabetes treated with a 15 mg pioglitazone dose in Korea: a multi-center retrospective cohort study.Distinguishing incident and prevalent diabetes in an electronic medical records databaseAcupuncture treatment for insulin sensitivity of women with polycystic ovary syndrome and insulin resistance: a study protocol for a randomized controlled trial.Deciphering the Roles of Thiazolidinediones and PPARγ in Bladder Cancer.Bladder cancer in 2012: Challenging current paradigms.Metabolic Surgery for Type 2 Diabetes in Patients with a BMI of <35 kg/m(2): A Surgeon's Perspective.The future of thiazolidinedione therapy in the management of type 2 diabetes mellitus.Rivoglitazone: a new thiazolidinedione for the treatment of type 2 diabetes mellitus.A clinician's guide to the ABCs of cardiovascular disease prevention: the Johns Hopkins Ciccarone Center for the Prevention of Heart Disease and American College of Cardiology Cardiosource Approach to the Million Hearts Initiative.Physiologic and weight-focused treatment strategies for managing type 2 diabetes mellitus: the metformin, glucagon-like peptide-1 receptor agonist, and insulin (MGI) approach.
P2860
Q28074506-CBFE1A5C-828D-458D-A8D4-04DAE3B6340FQ28535372-D40DF630-0CC4-4A5A-A614-DFF4BEC3AA7FQ28546969-C2B3FC08-CB72-4166-AF9B-FA35095E037BQ28597192-7C86668D-F157-4C54-9FB4-B00C19EB025FQ28829259-C8175133-581B-4FE2-B560-4B62688691D9Q30250347-1FEA5166-6BA9-4939-AC45-D6E29C61C454Q30385602-509CD9EF-3691-4072-AF7F-FF7BD8AFD4DCQ31139394-0E338E21-509A-45F0-BBFD-520DD0141B74Q33577712-4B572BB8-44AB-4E68-81F0-85008E8CAC8BQ33588852-E2096696-958D-46A2-9F49-95D2E64E1456Q33793812-27AF13A1-1F5A-40D2-BE92-CF25A5BE23B1Q34065266-9A9C371C-FD1F-4865-BEBC-3508E7C0A007Q34181385-08CA3F4C-F073-4CD6-B61F-6647BCA2A5D2Q34201551-88DC68C4-0D63-456C-9D4F-D5FC51678399Q34272097-96171710-1EEF-4BD4-A184-1F298A8F33BFQ34284885-88B4E1F6-BB86-4E44-8CF0-0E4CDF63CC57Q34383575-91F344CB-2C9A-4057-900C-3AC415E977DDQ34676639-A09279ED-3AC9-44A0-BAD4-DBF63C547FD1Q35141084-0D521E4A-6D74-4A69-9018-621FF9AB5009Q36163111-A40FD676-522F-443D-BB10-F38784232A34Q36365216-6E3AEC28-A3F7-43BD-8BCC-2DE76D4AD8B8Q36379016-7E4319E7-C404-4588-840D-E1033671FC94Q36562906-FAB7748C-4AE6-4B6F-A0B8-4EE79CF11253Q36581133-16F7104B-725A-4174-A963-8674AFB2CDEEQ36614839-DC5B60B4-365B-4F00-A9F8-2D964B56BD6EQ37015940-F414E3BD-7710-4315-8BFA-CCDBAC2DF0BAQ37180829-1650BE98-CE22-4FC9-AD1B-7ED1C2BC8025Q37352546-2C4894B2-59CA-4F92-86E3-35480A7AAB6CQ37433259-7F690148-FB28-4519-BCF8-8FD417D93B4DQ37577151-DA3CBDAB-1485-4DEC-9ACB-6BC561245D33Q37583052-66DE46EB-B4EA-49A3-9A30-66DA1E7D8466Q37593873-0501114A-50A2-4088-AC88-799111A0CBDCQ37690022-8624ECCA-9470-4EEF-BA27-3FCD4EB75A90Q37699907-B98D9DCA-2E8A-4F3A-B5E3-A4320DB94E76Q38072184-2AAB8E7D-8E65-4C6D-9F5D-98370FAC69D1Q38096980-4340EB83-5D3D-4A39-9CF8-0CFDFBCD18E0Q38102596-283DDD15-AAA4-4ABC-91AC-A5D32CEAF473Q38103131-3E8C0BEE-E5DF-41C2-8205-7C7028FDD8F9Q38106667-1AB4CD4A-BC5E-445D-B587-9825A4576E5FQ38113095-7851C9CB-82AF-4789-95BF-87AB71CCD1AF
P2860
Association between longer therapy with thiazolidinediones and risk of bladder cancer: a cohort study.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Association between longer the ...... ladder cancer: a cohort study.
@ast
Association between longer the ...... ladder cancer: a cohort study.
@en
type
label
Association between longer the ...... ladder cancer: a cohort study.
@ast
Association between longer the ...... ladder cancer: a cohort study.
@en
prefLabel
Association between longer the ...... ladder cancer: a cohort study.
@ast
Association between longer the ...... ladder cancer: a cohort study.
@en
P2093
P2860
P356
P1476
Association between longer the ...... ladder cancer: a cohort study.
@en
P2093
Brian L Strom
David J Vaughn
James D Lewis
Karen Glanz
Kevin Haynes
Ronac Mamtani
Warren B Bilker
P2860
P304
P356
10.1093/JNCI/DJS328
P407
P577
2012-08-09T00:00:00Z